Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 15, 2026

Sep. 15, 2026

SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development

Indeterminate GlobeNewswire

Sep. 15, 2026

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Indeterminate GlobeNewswire

Sep. 15, 2026

Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases

Indeterminate GlobeNewswire

Sep. 15, 2026

Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada

Indeterminate GlobeNewswire

Sep. 15, 2026

Thérapeutique Knight annonce la soumission réglementaire de GEMTESA® au Canada

Indeterminate GlobeNewswire

Sep. 15, 2026

Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026

Indeterminate GlobeNewswire

Sep. 15, 2026

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

Sep. 15, 2026

Altrova Health to Present at the Life Sciences Investor Forum on September 17th

Indeterminate GlobeNewswire

Sep. 15, 2026

Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence

Indeterminate GlobeNewswire

Sep. 15, 2026

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Sep. 15, 2026

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Indeterminate GlobeNewswire

Sep. 15, 2026

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Indeterminate GlobeNewswire

Sep. 15, 2026

Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS

Indeterminate GlobeNewswire

Sep. 15, 2026

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 15, 2026

Satellos to Present at the 31st Annual Congress of the World Muscle Society

Indeterminate GlobeNewswire

Sep. 15, 2026

Village Farms Welcomes Initial Government Findings from the Netherlands Regulated Cannabis Program

Indeterminate GlobeNewswire

Sep. 15, 2026

Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026

Indeterminate GlobeNewswire

Sep. 15, 2026

Art Meets Whiskey: Breckenridge Distillery Debuts Limited-Edition Collectors Series Release with Pat Milbery

Indeterminate GlobeNewswire

Sep. 15, 2026

Christina Lake Cannabis Announces Second Offer

Indeterminate GlobeNewswire

Sep. 15, 2026

VitalHub Announces Expansion of AI Capabilities with Launch of AI Scribe

Indeterminate GlobeNewswire